Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab. [electronic resource]
Producer: 20120326Description: 282-5 p. digitalISSN:- 1759-4820
- Adenocarcinoma -- drug therapy
- Adult
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab
- Fatal Outcome
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Organoplatinum Compounds -- administration & dosage
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.